New live-cell drug discovery tool identifies two leukemia drugs and other small molecules as potential treatments for lung tumours that stopped responding to therapy.
New live-cell drug discovery tool identifies two leukemia drugs and other small molecules as potential treatments for lung tumours that stopped responding to therapy.